The Diabetes Alliance has responded to the government's public consultation on funding and subsidies for health technologies and medicines.
Our response includes suggestions for improvement, including more flexible assessment processes, faster access through greater weighting of international approval, increased and more equitable access, and looking beyond clinical criteria in assessments of technologies and medicines.
Read a summary of our response here.